Inclusion Criteria:  spinal fusion procedures in skeletally mature patients with Degenerative Disc Disease (DDD) at one or two contiguous levels from L2 to S1. DDD is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies. These DDD patients may also have up to Grade I spondylolisthesis or retrolisthesis at the involved levels. Patients should have had six months of non-operative treatment prior to treatment with an intervertebral body fusion device.  Exclusion Criteria:  Patients unsuitable for anesthesia Active systemic infection, infection or suspected latent infection localized to the site of the proposed implantation Excessive local inflammation Rapid joint disease, bone absorption, osteopenia Severe osteoporosis or osteopenia Morbid obesity Pregnancy Open wounds Patients have demonstrated allergy or foreign body sensitivity to any of the implant materials Any medical or surgical condition which would preclude the potential benefit of spinal implant surgery, surgery, such as the presence of tumors, congenital abnormalities, elevation of sedimentation rate unexplained by other diseases, elevation of white blood cell count (WBC), or marked left shift in the WBC differential count Patients whose activity, mental capacity, mental illness, alcoholism, drug abuse, occupation, or lifestyle may interfere with their ability to follow postoperative restrictions and who may place undue stresses on the implant during bony healing and may be at a higher risk of implant failure Any patient in which implant utilization would interfere with anatomical structures or expected physiological performance Any condition not described in the indications for use